The developmental cell death in the nematode C. elegans is controlled by a simple and elegant genetic program (Metzstein et al., 1998) . In this program, transcriptional activation of egl-1 in cells destined to die commits the cells to their fate by producing Egl-1 protein, which directly binds to Ced-9, the guardian of cell survival in C. elegans. Binding of Egl-1 with Ced-9 disrupts the inhibitory complex of Ced-9 with adaptor protein Ced-4 and allows the latter to interact and activate Ced-3, the sole caspase required for all cells to undergo programmed cell death. Activation of Ced-3 leads to cellular destruction by cleaving specific substrates (Metzstein et al., 1998) . The demonstration of this dedicated genetic cell death program in C. elegans played a crucial role in legitimizing programmed cell death as a true genetically encoded cellular mechanism.
The early 1990s were an exciting time for the field of cell death. Work from the laboratory of Bob Horvitz showed that Ced-3 encodes a protein homologous to the mammalian interleukin-1b converting enzyme , later renamed caspase-1, and that the Ced-9 protein is homologous to Bcl-2 (Hengartner and Horvitz, 1994b ), a mammalian oncogene already known at that time as having a cell death inhibitory activity (Vaux et al., 1988) . These studies revealed the possible evolutionary conservation of this genetic cell death program from C. elegans to humans. The first set of direct evidence to support the functional similarity of mammalian caspases with that of Ced-3 in C. elegans came from my laboratory, when we showed that the expression of caspase-1 can induce apoptosis, which is inhibitable by Bcl-2, and that inhibition of caspase activation in neurons deprived of trophic factor can block apoptosis in cell culture (Miura et al., 1993; Gagliardini et al., 1994) . These discoveries played a crucial role in igniting an inflamed pursuit for the mammalian homologs of Ced-3, Ced-4, and Ced-9.
Today, more than a decade after these initial exciting days of discovery, we know that instead of a ced-3, a ced-4, and a ced-9 controlling all the programmed cell death in C. elegans, mammals have at least ten different caspases, multiple members of Bcl-2 family, and multiple Ced-4-like adaptor proteins such as Apaf-1 and NALPs (Danial and Korsmeyer, 2004; Degterev et al., 2003; Inohara and Nunez, 2003) . There are constant debates in the cell death field as to which caspases may be more important than others in controlling apoptosis and whether Apaf-1 is the ''true'' mammalian Ced-4 homolog (Marsden et al., 2002) , as none of the caspase or apaf-1 knockout mice displayed a phenotype of complete cell death inhibition as one would predict from elimination of a true mammalian ced-3 or ced-4 (Degterev et al., 2003) (Table 1) . A general explanation for the lack of a strong cell death phenotype for any caspase mutant mice has been the redundancy in the mammalian apoptosis system so that the loss of one caspase may be compensated by upregulation of other caspases (Zheng et al., 2000) .
Although the mammalian apoptosis system may be redundant indeed, one may wonder, however, how such a redundancy was selected during evolution. Clues to this question might be found through understanding the differences between the mechanisms of cell death in C. elegans and those in mammals, as well as the increased involvement of mammalian apoptosis proteins in normal physiological processes that are not directly related to cell death. Such evidence suggests that evolution has led to an extensive integration of mammalian apoptosis machinery with multiple cellular physiological processes, and as a result, the survival of mammalian cells becomes highly dependent upon appropriate internal and external signaling processes, and at the same time, cell death may be mediated by multiple mechanisms that are a part of normal cellular physiological processes.
Extensive Involvement of Mammalian Caspases in Host Defense Responses
Cell death serves as one of the most primitive mechanisms to defend against invading pathogens. In C. elegans, enhanced levels of programmed cell death were observed in gonadal cells when fed Salmonella and mutants with defects in the programmed cell death mechanism, including ced-3 (loss of function), ced-4 (loss of function), egl-1 (loss of function), and ced-9 (gain of function), were hypersensitive to Salmonella typhimurium (Aballay and Ausubel, 2001) . Thus, the programmed cell death mechanism in C. elegans may serve as a protective mechanism against certain pathogens such as Salmonella. It is not clear, however, whether this protective mechanism is directly related to the increased gonadal cell death or the programmed cell death might provide an indirect protective mechanism (such as regulating cytokine secretion) against Salmonella.
The host defense role has been significantly expanded for mammalian caspases, which play important roles in regulating innate immunity, the primitive cellular defense mechanism. In fact, caspase-1, the first mammalian caspase identified, was isolated as the cysteine protease responsible for processing pro-interleukin 1b (pro-IL-1b) into mature IL-1b (Thornberry et al., 1992) . Later on, it was discovered that caspase-1 was also responsible for processing pro-IL-18 into mature IL-18, a potent cytokine capable of inducing a multitude of immune responses, including the secretion of interferon g (Reddy, 2004) . Two additional caspases, murine caspase-11 and its human ortholog, caspase-5, indirectly regulate cytokine secretion by mediating the activation Fewer facial motor neurons at birth, which becomes normal by postnatal day 7. (Bergeron et al., 1998; Troy et al., 2000) caspase-3
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Dilation of the atria and disorganization of the ventricular musculature. (Lakhani et al., 2006) Molecular Cellof caspase-1 (Degterev et al., 2003; Wang et al., 1998; Martinon et al., 2002) . Similar to that of Ced-3 in C. elegans, mammalian caspases also function to mediate apoptosis cell-autonomously in response to the invasion of certain pathogens. For example, both caspase-1 and caspase-2 may contribute to apoptosis of macrophages invaded by Salmonella. The activation of caspase-1 occurs rapidly and may be responsible for early apoptosis of macrophages induced by Salmonella (Hersh et al., 1999) ; on the other hand, the activation of caspase-2 and other downstream caspases, such as caspase-3, may contribute to the later stage apoptosis of macrophages (Jesenberger et al., 2000) . Thus, multiple caspases may function in innate immunity by mediating pathogeninduced apoptosis.
Caspases are also involved in adaptive immunity. T cell-specific caspase-8-deficient mice had fewer mature T cells in the spleens and lymph nodes than wild-type, and caspase-8-deficient T cells showed a defect in proliferation (Salmena et al., 2003) . Interestingly, a rare subset of patients with autoimmune lymphoproliferative syndrome (ALPS) were found to have inherited a missense mutation in the caspase-8 gene (Chun et al., 2002) . These unusual ALPS cases not only exhibited lymphadenopathy, spenomegaly, and impaired Fas-induced apoptosis but also showed recurrent infections indicative of immunodeficiency associated with a deficiency in T cell proliferation. These studies indicate that caspase-8, in addition to its role in mediating death receptor-mediated apoptosis, also plays a role in positively regulating adaptive immune response. Because the expression of crmA, a serpin encoded by cowpox virus that inhibits caspase-8, in T cells of transgenic mice is sufficient to inhibit Fas-mediated apoptosis, but not sufficient to block proliferation (Smith et al., 1996) , perhaps only a small amount and/or localized caspase-8 is sufficient to mediate the activation of T cells.
The proliferation of B cells may also be regulated by caspases (Chun et al., 2002) . Caspase-6 plays a role in the entry of quiescent B cells into G1 phase of the cell cycle upon stimulation (Olson et al., 2003) , whereas caspase-3 acts to restrict the proliferation of B cells by cleaving the cyclin-dependent kinase inhibitor (CDKI) p21 Cip1/Waf1, which removes its C-terminal tail involved in promoting cell proliferation by interacting with proliferating cell nuclear antigen (PCNA) (Woo et al., 2003) . The involvement of caspases in the proliferation indicates that the roles of mammalian caspases have been expanded considerably beyond that of apoptosis.
Because multiple members of caspase family in the mammalian genome are likely to have arisen during evolution by gene duplication, the extensive roles of caspases in positively regulating both innate immunity and adaptive immune response suggests that an increased ability to defend against pathogens might provide an important selection force during the evolution of cell death mechanisms. Although caspases clearly play an important role in the removal of unwanted autoreactive immune cells, developing additional defense strategies against invading pathogens had clearly been a priority goal for complex organisms during evolution. Inheritance of caspase duplications in the genome may be favorable if they offer survival advantages by protecting organisms against foreign pathogens. In addition, the dual role of caspases in regulating lymphocyte proliferation and death may provide a protective mechanism against autoimmunity to ensure that only cells with healthy apoptosis machinery are allowed to proliferate.
Dual Roles of NOD Family in Apoptosis and Inflammation
The extensive roles of caspases in regulating both innate and adaptive immunity predict that the adaptor proteins regulating their activation should be involved in controlling cellular defense as well and that is exactly what has been found. Apaf-1 is one of the expanding family nucleotide binding oligomerization domain (NOD) containing proteins (Inohara and Nunez, 2003) . The NOD domains are a part of the nucleotide binding P loop closely related to the oligomerization module found in AAA + ATPase and predicted to have nucleotide triphosphatase activity. Indeed X-ray crystal structural analysis of WD40-deleted Apaf-1 revealed the ability of Apaf-1 to hydrolyze ATP . Some members of the NOD family, such as Apaf-1, Nod1 (Ipaf), and Nod2, contain an N-terminal CARD domain, which mediates the homophilic interaction with the CARD domain of caspases. Other members, such as 14 NALP proteins, contain the pyrin domain in their N terminus. At least some of the pyrin-containing NALPs, such as NALP1-3, interact with ASC, a pyrin-CARD containing adaptor protein, which in turn binds the CARD domain of caspase-1 to form a protein complex termed ''inflammasome'' (Martinon et al., 2002) . Macrophages from ASC 2/2 mice are severely impaired in their ability to activate caspase-1 and secrete IL-1b in response to multiple intracellular bacterial pathogens, including Salmonella typhimurium, Francisella tularensis, Listeria monocytogenes, and Staphylococcus aureus, indicating a critical role of the adaptor protein ASC for the activation of caspase-1 induced by multiple intracellular pathogens (Mariathasan et al., 2004; Mariathasan et al., 2005) .
Except for Apaf-1 and Nod8, most members of the NOD family contain C-terminal LRR regions (LRRs) that are also present in the Toll-like receptors. Different LRR-containing members of the NOD family may function as detectors for pathogen-associated molecular patterns (PAMPs) to signal our immune system of impending danger and to activate the innate immune response (Janeway and Medzhitov, 2002) . Recently, NALP3 has also been shown to be required for the activation of caspase-1 induced by bacterial RNA (Kanneganti et al., 2006) , certain toxins (Mariathasan et al., 2006) , and gout-associated uric acid crystals (Martinon et al., 2006) . Ipaf (Nod1) is required for the formation of Salmonella-mediated inflammasome, whereas both NALP3 and ASC are required for Listeria and Staphylococcus-induced inflammasome (Mariathasan et al., 2006) . Thus, the formation of inflammasomes is a highly dynamic signaling-specific process with the ultimate goal of activating caspase-1.
Although the functions of many members of the NOD family are still unknown, it is likely that different LRR domains in these proteins function as sensors for different PAMPs. The large NOD family with LRR-containing pathogen sensors underscores the expanding role of caspases and their regulators in host defense responses.
Caspases Regulate Multiple Nonapoptotic Processes
Regulation of host defense responses is not the only nonapoptotic function of caspases. Increasing evidence suggests that caspases may play important roles during development to regulate cell proliferation and differentiation in addition to regulating apoptosis (Table 1) . Although most of caspase knockout mice (caspase-1
, and caspase-12 2/2 ) are developmentally normal, the majority of apaf-1 2/2 mice and caspase-9 2/2 mice die perinatally with a markedly enlarged and malformed cerebrum with evidence of reduced apoptosis (Cecconi et al., 1998; Kuida et al., 1998; Yoshida et al., 1998) . Although the brain morphological distortion of apaf-1 2/2 and caspase-9 2/2 mice may be attributable to apoptosis deficiency, it is interesting to compare them with the brains of Bcl-2 transgenic mice that exhibit remarkable hypertrophy but without overall morphological distortion (Martinou et al., 1994) . The phenotypes of Bcl-2 transgenic mice argue that blocking apoptosis during development does not necessarily lead to an alteration in the gross morphology of the brains, suggesting additional nonapoptotic functions of caspase-3 and caspase-9 in shaping the central nervous system during development. In an intriguing detailed analysis of apaf-1 2/2 and caspase-9 2/2 mice, Cecconi et al. (2004) demonstrated that apaf-1 and caspase-9 deficiency led to not only a reduction of apoptosis in the inner ear epithelium but also a severe morphological defect. Although the morphological defects in the inner ear of apaf-1 2/2 and caspase-9 2/2 mice may be caused by apoptosis deficiency, an alternative possibility yet to be examined is that apaf-1 and caspase-9 may be involved in the morphogenesis of inner ear independent of its activity in regulating apoptosis.
Caspase-8 serves vital functions during development. caspase-8 2/2 or caspase-8 DED/DED (expressing a truncated caspase-8 DED domain without the caspase domain) mice exhibit severe defects in embryonic development, including cardiac rupture with evidence of increased apoptosis, neural tube malformation, and defects in hemopoietic progenitor cell development, and die during early embryonic development (Sakamaki et al., 2002; Varfolomeev et al., 1998) . Interestingly, the defects in the cardiac and neural tube development can be corrected by culturing the embryos in vitro, suggesting the possibility that caspase-8 is required for the release of a key signaling factor critical for cardiac and neural development (Sakamaki et al., 2002) . Intriguingly, similar defects in cardiac development were observed in mice deficient for other death receptor-signaling molecules such as FADD (Yeh et al., 1998) and FLIP (Yeh et al., 2000) , as well as in caspase-3 2/2 ; caspase-7 2/2 double-deficient mice (Lakhani et al., 2006) , suggesting perhaps that the death receptor signaling has a yet unknown role in regulating embryonic heart development.
Activation of caspase-3 under nonapoptotic conditions has been widely documented, largely due to the availability of a good anti-caspase-3 antibody specific for its activated form. In the nervous system, increasing evidence suggests that caspase-3 may regulate synaptic plasticity and growth cone motility. Mattson and Duan showed that caspase activation occurred locally in synaptic terminals in response to various stimuli, suggesting that low levels of caspase activation may play a role in adaptive responses to stress and/or normal synaptic activities (Mattson and Duan, 1999) . Inhibition of caspases may block long-term spatial memory, suggesting that caspase-mediated cellular events in hippocampal neurons may be critical for long-term spatial memory storage. Although definitive evidence for the role of caspases in normal nervous system functions has yet to be obtained, the possible involvement of caspases in multiple neuronal processes cannot be ignored.
Thus, although overexpression of any long-prodomain caspases can induce apoptosis by processing and activating endogenous caspases to produce a caspase cascade that leads to cell death, low levels of and/ or localized caspase activity may be involved in multiple physiological processes unrelated to apoptosis. Although the activation of caspase-3 in nonapoptotic conditions is best documented, it is likely that activation of many other caspases may be found under nonapoptotic conditions in future studies.
Regulation of Apoptosis by Cellular Metabolism
The extensive involvement of mammalian caspases in multiple noncell death-related mechanisms suggests that caspases have acquired new functions during evolution. As a result, caspases have evolved from an exclusive regulator of cell death in primitive organisms to a versatile signal transduction mechanism integrated in a variety of cellular physiological processes. A direct consequence of this integration, as one might expect, is that the apoptosis mechanism becomes highly sensitive to the cellular physiological status. Apoptosis has been recognized as the ''default'' fate of mammalian cells in the absence of growth or trophic factors (Raff, 1998) . Interestingly, glucose metabolism might be the primary downstream mechanism responsible for cell survival regulated by trophic factors (Gottlob et al., 2001 ). Activation of phosphatidylinositol 3 phosphate kinase (PI3 kinase) after binding of growth factors to their receptors leads to the activation of Akt, a major mediator of the antiapoptotic effect of growth factors. Surprisingly, Akt can promote cell survival in the absence of new macromolecule synthesis but requires glucose and glucose metabolism (Rathmell et al., 2003) . Expression of activated Akt increased glucose uptake and phosphorylation by promoting the localization of the Glut1 glucose transporter to the cell surface, total cellular hexokinase activity, and pentose phosphate shuttle activity. Overexpression of Glut1 and hexokinase 1 (HK1) was able to partially recapitulate the ability of Akt to maintain cellular NADH and NADPH levels and suppress Bax activation induced by trophic factor deprivation. Subsequently, it was found that at least a part of the mechanism by which Akt regulates cellular metabolism is to directly interact with mitochondrial hexokinase (HK) and promote the association of HK with mitochondria (Majewski et al., 2004) . HKs are also known to bind to the voltage-dependent anion channel (VDAC), a protein localized on the outer mitochondrial membrane required for the maintenance of normal mitochondrial homeostasis and ATP production through regulating the flux of metabolites across the outer membrane and directly coupling intramitochondrial ATP synthesis to glucose metabolism (Beutner et al., 1998) . By promoting mitochondrial association of HKs, Akt might directly impact on the permeability of the transport pores and increase the coupling of glucose metabolism to oxidative phosphorylation.
Phosphorylation of glucose by HK to form membraneimpermeable glucose-6-phosphate (G6P) is a key step in glucose metabolism. Recently, the Kornbluth group showed that the addition of G6P to Xenopus egg extract is sufficient to inhibit spontaneous caspase activation (Nutt et al., 2005) . Interestingly, it was discovered that the cellular levels of NADPH produced by the pentose phosphate pathway play a key role in inhibiting apoptosis of frog oocytes through promoting an inhibitory phosphorylation of caspase-2 mediated by a calcium/ calmodulin-dependent protein kinase II (CaMKII). Interestingly, glucose-6-phosphate dehydrogenase activity, which promotes the metabolism of glucose through the pentose phosphate pathway, has been shown to protect CHO cells from death induced by ionizing radiation (Biaglow et al., 2000) . Thus, glucose metabolism might regulate apoptosis by directly controlling the activation of caspases.
Other intermediate metabolites may also contribute to the regulation of apoptosis. The production of reactive oxygen species (ROS), an inevitable consequence of metabolism, has long been proposed to contribute to cell death (England and Cotter, 2005) . Although high levels of ROS are known to induce cell death, increasing evidence suggests that ROS can act as an intracellular signaling mechanism by modifying proteins through multiple covalent modifications, including nitrosylation, carbonylation, disulphide bond formation, and glutathionylation. For example, caspase-3 has been shown to be modified by S-nitrosylation on the catalytic-site cysteine that inhibits its activity (Mannick et al., 1999) . Redox modification of signaling proteins involved in regulating cell survival provides another direct coupling mechanism from metabolism to cell death.
Bcl-2 Family Couples the Cell Death Programs with Internal and External Signaling
Whereas the induction of egl-1 expression pronounces the death sentence for cells during the development of C. elegans, mammalian proapoptotic Bcl-2 family members definitely do not regulate the pathway with a single ''on-or-off'' switch. Instead, the mammalian genomes encode many Egl-1-like BH3-domain only members of Bcl-2 family that function to promote apoptosis in a partially redundant fashion (Puthalakath and Strasser, 2002) . Although the transcriptional activation of certain mammalian BH3-only proapoptotic members of Bcl-2 family, like that of egl-1 in C. elegans, remains as one of the regulatory mechanisms, the manner by which mammalian BH3-only Bcl-2 family are activated have been significantly diversified to include phosphorylation (Datta et Luo et al., 1998) , and N-myristoylation (Zha et al., 2000) . The diverse regulatory mechanisms of apoptosis activation made it possible to rapidly respond to a multitude of complex internal and external stress signals.
Different BH3-only Bcl-2 family members regulate apoptosis in a cell type and tissue-specific and stimulispecific manner. Bim plays the most important role in regulating apoptosis of lymphoid and myeloid cells induced by cytokine withdrawal, but not that of erythrocytes and megakaryocytes (Bouillet et al., 1999) . Bid plays a role in the liver regulating Fas-induced hepatocyte death (Yin et al., 1999) . Hrk/DP5 may play a role mediating neuronal cell death induced by NGF withdrawal (Imaizumi et al., 1997) . Noxa and Puma are regulated by p53 and mediate apoptosis in response to DNA damage (Nakano and Vousden, 2001; Oda et al., 2000) , whereas Bmf is activated by UV irradiation and anoikis (Puthalakath et al., 2001) . Because BH3-only Bcl-2 proteins serve as the intracellular sensors triggering apoptosis induction in response to a variety of intracellular stimuli, the diversification of this family is likely to have arisen for a need to provide a much more complex and precise regulation of apoptosis signaling in response to a greatly increased number of stimuli.
Interestingly, one of the BH3-only family members, Bad, has recently been shown to play a dual role in regulating cellular metabolism and apoptosis. Bad is regulated by phosphorylation in response to survival factors and the activation of oncogenic kinases such as Akt, Pim-2, and Ras-MAPK. Interestingly, Bad was also found to associate with a mitochondrial complex containing the liver-specific isoform of hexokinase, glucokinase. In the Bad 2/2 mice, this complex is dissociated from the liver mitochondria, which impairs the mitochondria-associated glycolytic activity and respiration (Danial et al., 2003) . Phosphorylation of Bad, although not required for the association of the glucokinase complex with mitochondria, is needed for the normal activity of glucokinase. Dephosphorylation of Bad after glucose and/or growth factor withdrawal might promote Bad apoptosis at the level of the mitochondria, perhaps in part by inhibiting the activity of glucokinase, which can directly contribute to an irreversible decline in cellular metabolism. Thus, Bad may play an important part in bridging the regulation of cellular metabolism and apoptosis, and furthermore, the negative metabolic effects observed in Bad 2/2 cells may point to the critical importance of this regulatory point in the normal cellular surveillance mechanisms.
Although C. elegans Bcl-2 homolog, Ced-9, may have both anti-as well as prodeath activity (Hengartner and Horvitz, 1994a) , the mammalian apoptosis checkpoint is regulated by multiple anti-and prodeath Bcl-2 family members. Overexpression of antiapoptotic Bcl-2 or Bcl-xL or mutating both proapoptotic Bcl-2 family members, Bax and Bak, protects cells from apoptosis induced by a multitude of proapoptotic stimuli, such as growth factor withdrawal, DNA damage, and cytotoxic chemicals. Thus, the normal physiological balances of Bcl-2/Bcl-xL to that of Bax/Bak may function as a critical control point upstream of mitochondrial permeability.
The role of Bcl-2 family members in regulating cytochrome c release and subsequent basic apoptotic steps is well characterized. Many members of Bcl-2 family have been shown to interact with VDAC, an important passage for the flux of metabolites across the outer membrane. Changes in the permeability of the mitochondrial outer membrane have been recognized as an early event during apoptosis. Bcl-xL has been shown to interact with VDAC (Shimizu et al., 1999) , whereas Bak has been shown to bind to a minor isoform of VDAC, VDAC2 (Cheng et al., 2003) . Because VDAC also associates hexokinases (Azoulay-Zohar et al., 2004) , the interaction of Bcl-2 family with VDAC may be significant not only for the metabolite traffic control in the mitochondria but also to provide a fine-tuning mechanism for the rate of glycolysis, both of which can in turn regulate the rates of mitochondrial respiration and ATP production. Because cancer cells demonstrate significant differences in the mode and rates of metabolism compared to normal cells, these data suggest that Bcl-2 family may contribute to the metabolic changes of cancer cells as well as to promote their survival. The extensive contribution of the mammalian Bcl-2 family in coupling cellular metabolism with apoptosis provides another example of increased involvement of apoptotic machinery in regulating normal cellular physiology.
Evolutionary Recruitment of Noncell Death Mechanisms
Evolution has not only integrated a dedicated cell death pathway in primitive organisms with multiple cellular physiological processes but has also led the complementary process to occur simultaneously, i.e., multiple noncell death mechanisms have now been recruited to regulate cell death under different conditions. This is evident as inhibition of caspases in mammals is largely insufficient to block cell death and promote clonogenic survival in many instances (Ekert et al., 2004) . Many examples of such recruitment have been documented in the literature (Table 2) , and I will discuss a few of such examples below.
Cytochrome C: An Angel Lives a Double Life
Cytochrome c is a key electron carrier of mitochondrial complex III in the electron transport chain and is present in all organisms that have mitochondrial respiration. Surprisingly, given its critical role in the basic cellular energy production, cytochrome c has also adapted a regulatory role in cell death. Cytochrome c is released when mitochondria are damaged during apoptosis (Liu et al., 1996) . Although a general role of cytochrome c in mediating programmed cell death in C. elegans or Drosophila has not been demonstrated, the release of cytochrome c has been recognized as a common event mediating caspase activation downstream of mitochondrial damage in mammalian cells. Cytosolic cytochrome c (Cyt c) binds to apoptotic protease-activating factor 1 (Apaf-1) in the presence of dATP or ATP to form the apoptosome (Li et al., 1997 ). An important function of apoptosome is to recruit procaspase-9 via its caspase recruitment domain (CARD) and promote its activation (Zou et al., 1999) . Active caspase-9 in turn activates the downstream effectors caspase-3 and -7 (Li et al., 1997; Liu et al., 1996) , which rapidly cleave multiple intracellular substrates to complete the execution of apoptosis.
The WD40 repeats at the C-terminal of Apaf-1 possess an inhibitory activity toward apoptosome activation (Ferraro et al., 2003) . A cryo-EM analysis of apoptosome provided a model suggesting that 13 WD40 repeats might form two b propellers of seven and six blades that are characteristic of WD40 repeats (Yu et al., 2005) . According to this model, binding of a single cytochrome c molecule between two b propellers causes a conformation change that releases the inhibition. It is interesting to speculate that perhaps the C-terminal LRRs in other members of NOD family might also have inhibitory function and that binding of the LRRs with the respective PAMPs from different pathogens might release the inhibition and lead to the activation Released from mitochondria to cytosol to facilitate apoptosome formation (Liu et al., 1996) Cyclophilin D Mitochondrial prolyl isomerase and the target of cyclosporine A. Involved in mitochondrial permeability transition.
Involved in necrosis-induced mitochondrial permeability transition. Mediate cell death in certain apoptosis deficient cells.
( Levine and Yuan, 2005; Shimizu et al., 2004; Yu et al., 2004) Lysosome Acidic hydrolases involved intracellular protein turnover.
Lysosomal membrane permeabilization leads to the release of hydrolases to induce caspase-dependent and independent cell death. (Kroemer and Jaattela, 2005) of caspase-1. Thus, the C-terminal regulatory domains of the NOD family might represent a general mechanism to couple the basic apoptotic and cytokine secretion machinery to a variety of upstream signals, including mitochondrial damage, as well as invasion of pathogens. Recent molecular structural studies also pointed out the considerable differences in the manner by which Ced-4 and Apaf-1 are activated: Ced-4 is activated by the removal of Ced-9, whereas binding of cytochrome c to Apaf-1 triggers the formation of apoptosome. Ced-4 is devoid of a C-terminal WD40 domain, which nicely explains why cytochrome c is not required for the activation of Ced-4. Although both Ced-4 and Apaf-1 contain a domain homologous to the AAA + family of ATPase, Ced-4 only binds ATP and is devoid of detectable ATPase activity, whereas Apaf-1 can bind ADP and exhibits considerable ATPase activity (Yan et al., 2006) . The structural basis for these differences, as demonstrated by elegant structural studies from Yigong Shi's laboratory, is that Ced-4 exists as an asymmetric dimer when inhibited by Ced-9, whereas active Ced-4 is a tetramer. On the other hand, a cryo-EM study of apoptosome revealed that Apaf-1/cytochrome c/caspase-9 complex exists as a wheel-shaped heptameric complex (Acehan et al., 2002) . Although mitochondrial damage might also contribute to some aspects of programmed cell death in C. elegans, the removal of Ced-9 by Egl-1 is sufficient to allow Ced-4 to activate Ced-3, consistent with a simple on-or-off mode of regulation in primitive organisms. On the other hand, mitochondrial cytochrome c release in mammalian cells, which primarily serves to amplify apoptotic signal, provides additional options for tight control of apoptotic pathway in higher organisms. The development of the mitochondrial regulatory step of apoptosis required simultaneous evolution of a Ced-4-like factor, i.e., Apaf-1, to have incorporated a negative WD40-regulatory domain. Because the metabolic regulation of cell death also centers on mitochondria, it is intriguing to speculate that the mitochondrial step and ATP dependence of Apaf-1 function might have evolved to allow bidirectional coupling of cell death with cellular metabolism.
Mitochondrial Permeability Transition: A Passage from Life to Death
The permeability of mitochondria is tightly regulated. Whereas the VDAC localized on the outer membrane makes the membrane permeable to many small molecules and ions, the special carriers on the inner membrane are required to carry metabolites in and out of mitochondrial matrix. The inner membrane is otherwise nearly impermeable to all ions and polar molecules. In vitro mitochondria can undergo a permeability increase to molecules smaller than 1500 Da in response to Ca 2+ , which has been termed mitochondrial permeability transition (mPT) (Zoratti and Szabo, 1995) . mPT results in a loss of mitochondrial membrane potential (DJ) as well as swelling and rupture of the outer membrane. Although transient induction of mPT under normal physiological condition might be involved in the fast release of Ca 2+ from mitochondria, the persistent activation of mPT has been implicated in both apoptosis and necrosis. The latter is a form of energy-independent cell death in response to noxious insults (such as lack of oxygen) and is characterized by cell swelling and plasma membrane permeabilization.
The mPT pore is believed to consist of the adenine nucleotide translocator (ANT), a VDAC, and cyclophilin D (CypD), a prolyl isomerase located within the mitochondrial matrix. In the absence of CypD, mPT can still occur but requires a higher concentration of Ca 2+ (Baines et al., 2005; Nakagawa et al., 2005; Schinzel et al., 2005) and becomes insensitive to the inhibition of cyclosporine A. CypD-deficient cells are only resistant to necrosis induced by oxidative stress and remain sensitive to apoptosis (Nakagawa et al., 2005) , underscoring the critical role of mPT in oxidative stress-induced necrosis. Therefore, although a change in the permeability of outer mitochondria leads to the release of cytochrome c and other proapoptotic factors to mediate apoptosis downstream of mitochondria, the permeability change of the inner mitochondrial membrane may be important for necrosis.
Thus, although mitochondria serve a vital function in living cells as the cellular energy factory, mitochondrial damage has deadly implications in multiple cell death paradigms, including mediating apoptosis by releasing cytochrome c and necrosis by mPT. The evolutionary incorporation of vital signs of critical intracellular organelles into the cell death pathways as sensors or amplifiers may have risen from the necessity to better monitor the internal metabolic energy levels in multicellular organisms.
Poly(ADP-Ribose) Polymerase-1: A Mender and a Killer Poly-ADP-ribosylation is a posttranslational modification of proteins involved in DNA repair . Poly(ADP-ribose) (PAR) is a large, negatively charged posttranslational modification produced through successive transfer of ADP-ribosyl moiety from NAD + to glutamic acid, aspartic acid, or lysine residues of target proteins by PAR polymerases (PARPs). There are at least 18 PARPs in the human genome, several of which have unknown functions. PAR modifications are dynamic: regulated by the balance between synthesis by PARP and hydrolysis by PAR glycohydrolase (PARG). PARP-1 is an abundant nuclear DNA binding protein that is activated by single-strand and double-strand b breaks DNA damage and facilitate DNA repair under moderate DNA damage . Most nuclear proteins subject to poly-ADP-ribosylation are DNA binding proteins such as histones, transcriptional factors, topoisomerases, DNA ligases, and DNA and RNA polymerases. The highly negative charged ADP-ribose polymers may be important for the recruitment of repair enzymes to the damaged site or chromatin structural changes required for DNA repair or both.
Cell death induced by alkylating DNA agents, such as mechlorethamine hydrochloride (nitrogen mustard) and N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG), is independent of the DNA damage-induced apoptosis mediators such as p53, Bax/Bak, or caspases but is inhibited by PARP inhibitor, such as nicotinic acid analog DPQ, and shRNA that reduces the expression of PARP-1 (Zong et al., 2004) . Furthermore, DPQ is significantly more effective in inhibiting the death of Bax/Bak DKO MEF cells induced by alkylating DNA agents than that of wild-type. Interestingly, wild-type, but not Bax/Bak DKO MEF cells, can be induced to undergo apoptosis, which leads to caspase-dependent cleavage and inactivation of PARP-1, an early nuclear event in apoptosis that prevents the depletion of NAD and ATP. The inability of Bax/ Bak DKO MEF cells to activate caspase-dependent apoptosis might result in more sustained PARP activation in response to alkylating DNA agents than that of wildtype cells, although no obvious difference was observed on the PAR levels in wild-type and Bax/Bak DKO cells by using the available assay (Zong et al., 2004) .
Interestingly, Zong et al. (2004) also demonstrated that PARP activation mediated by DNA alkylating agents led to a preferential depletion of cytosolic, but not mitochondrial, pools of NAD + . A decreased NAD:NADH ratio as a result of NAD depletion would adversely affect all cytosolic processes that require NAD as a cofactor, including glycolysis and pentose shunt. Because cytosolic and mitochondrial NAD pools are used in glycolysis and oxidative phosphorylation, respectively, to generate ATP, the cellular dependency on glycolysis might determine the sensitivity to NAD depletion and PARP activation-induced necrosis.
Depletion of cytosolic NAD might also explain how PARP activation leads to neuronal injury under pathological conditions. parp-1 2/2 mice are partially protected against ischemic neuronal injury (Ha and Snyder, 1999) . Sensitivity of neurons to NAD + depletion as a result of PARP activation might be explained by their mitochondrial deficiency and their dependency on glycolysis for survival. Consistent with a glycolytic block during ischemic neuronal injury, massive supplement of the glycolytic end product pyruvate has been shown to reduce neuronal injury in a transient forebrain ischemia model in rats .
The evolutionary adaptation of PARP-1-regulated cellular repair mechanism to mediate necrotic cell death may have the significance to ensure the removal of severely damaged cells that are unable to be repaired or to die by apoptosis. The tight coupling of this necrosis mechanism to the depletion of NAD + and ATP, two vital cellular resources, provides a means to eliminate damaged cells through an energy-independent fashion.
Autophagy: A Form of Self-Cannibalism Mediates Both Cell Survival and Cell Death Autophagy is a cellular catabolic mechanism involved in the turnover of intracellular organelles and large protein complexes through a lysosomal degradation pathway (Levine and Yuan, 2005) . The autophagosome, a membranous vesicular compartment, sequesters cytoplasmic constituents, including mitochondria, endoplasmic reticulum, and ribosomes. The outer membrane of the autophagosome eventually fuses with the lysosome (in mammalian cells) that leads to the degradation of the sequestered material by lysosomal proteases. Seventeen evolutionarily conserved ''atg'' genes were found to regulate autophagy from yeast to man. Autophagy serves an important homeostatic function under normal conditions and can be rapidly upregulated when cells are under stress.
Autophagy has an evolutionarily conserved prosurvival function by allowing recycling of membrane lipids and proteins by the autolysosome to fuel mitochondrial ATP energy production and maintain protein synthesis when cells are stressed due to limited nutrient supply or inability to take up nutrients from the environment. Autophagy-deficient yeast strains are hypersensitive to nutritional starvation conditions (Levine and Yuan, 2005) . Autophagy may serve a similar role in mammalian cells to delay the onset of apoptosis during nutrient deprivation (Boya et al., 2005) . Mice lacking Atg5, a key autophagy gene, die during the neonatal period, when autophagy is required to sustain life by recycling intracellular material after the sudden interruption of the placental blood supply (Kuma et al., 2004) .
On the other hand, the discovery of a subset of cell death during development with features of excessive autophagy has led to the term ''autophagic cell death.'' Morphological evidence of autophagic cell death has been associated with elimination of tissues en mass, such as that which occurs during insect metamorphosis and mammary gland postlactational involution. A definitive functional proof for the involvement of autophagy cell death in development, however, has been lacking. On the contrary, the expression of caspase inhibitor p35 was able to block metamorphic cell death in Drosophila without complete inhibition of autophagy, suggesting that autophagy may represent an ancillary event involved in the clearance of dead cells rather than an execution process during metamorphic cell death (Lee and Baehrecke, 2001) .
Recent studies, however, demonstrated that autophagy may indeed function to mediate cell death under special circumstances. Thompson et al. showed that cytokine-deprived Bax/Bak DKO MEF cells can survive by self-cannibalizing though autophagy (Lum et al., 2005) . Interestingly, when Bax/Bak DKO MEF cells are treated with proapoptotic stimuli, these cells die through autophagy, as RNAi against the autophagy genes, such as atg5 and beclin 1, prevented the death of bax/ bakDKO MEF cells treated with staurosporine or etoposide. Thus, autophagy, which may be more active in apoptosis-deficient bax 2/2 /bak 2/2 MEFs, can be activated to mediate cell death when induced by a proapoptotic stimulus (Shimizu et al., 2004) . In another study, Yu et al. (2004) found that RNAi directed against two different autophagy genes, atg7 and beclin 1, blocked cell death in mouse L929 cells treated with the caspase inhibitor zVAD. The survival of L929 cells might require caspase-8, perhaps reminiscent of the prosurvival and prodifferentiation role of caspase-8 during the development of hemopoietic progenitors, myelomonocytic cells, and macrophages (Kang et al., 2004) . These studies provide a glimpse into the mechanistic connection between autophagy and caspases regulated physiological functions and suggest that, although autophagy primarily serves as a prosurvival mechanism, it may be activated to induce cell death under certain conditions. Necroptosis: A Caspase-Inhibited Necrosis Mechanism Because evolution may have recruited programmed necrosis into the repertoire of mammalian cell death mechanisms, and that mammalian cells may die through either apoptosis or necrosis in response to a prodeath signal, one may wonder how a cell chooses the method to carry out its own execution. An answer to this question might be provided by the death receptor-mediated necrosis termed necroptosis (Degterev et al., 2005) .
Activation of the Fas and TNF family of death receptors leads to the activation of distinct downstream signaling pathways, including NF-kB and the prototypic apoptotic pathway mediated by caspases. Two different intracellular signaling complexes have been detected after TNFa stimulation (Micheau and Tschopp, 2003) : the membrane bound complex I contains TNF-R1, adaptor proteins TRADD and TRAF2, and a death domain-containing Ser/Thr kinase, RIP1; the soluble complex II contains TRADD, RIP1, TRAF2, FADD, caspase-8, and caspase-10. The complex I promotes cell survival by mediating the activation of NF-kB; whereas the activation of the complex II leads to apoptosis by activating caspases. Because RIP1-deficient cells are unable to mount any NF-kB response upon TNF stimulation, the presence of RIP1 in the complex I is consistent with its prosurvival role through activation of NF-kB (Kelliher et al., 1998) . In accordance with this, RIP1 has been shown to activate IKK, an upstream kinase that phosphorylates an NF-kB inhibitor (IkB), in a kinase-independent manner (Devin et al., 2000) . On the other hand, the expression of the death domain of RIP1 is sufficient to induce apoptosis (Devin et al., 2000) , suggesting that the interaction of RIP1 with caspases in the complex II might be to mediate apoptosis. RIP1 is rapidly cleaved at aspartic residue 324 by caspase-8 after TNFa, FasL, and TRAIL stimulation, and the C-terminal death domain containing RIP1 fragment promotes apoptosis, but not NF-kB activation. Thus, the cleavage of RIP1 might represent a transition point from NF-kB activation to apoptosis.
Interestingly, inhibition of caspases in multiple cell lines was found to be insufficient to prevent cell death induced by FasL and TNFa; although apoptosis was inhibited by caspase inhibitors, the cell death continued with necrotic morphology. These observations raised the possibility that when certain cells are stimulated by FasL or TNFa but are unable to execute apoptosis, these cells may adapt a ''programmed necrosis'' or necroptosis pathway and die through this alternative mechanism (Degterev et al., 2005) . Indeed, a small molecule inhibitor of necroptosis, necrostain-1, was found to specifically inhibit necroptosis in multiple cell lines. Interestingly, unlike NF-kB and apoptosis activation, the kinase activity of RIP1 is specifically required to mediate necroptotic pathway. Because RIP1 is cleaved early during apoptosis mediated by FasL and TNFa by caspase-8, separation of the kinase domain and the DD of RIP1 might provide a mechanism for caspase-dependent inhibition of necroptosis. Thus, necroptosis might represent a ''backup'' cell death mechanism when apoptosis fails to occur and play an important role mediating pathological cell death. The evolutionary recruitment of multiple cell death mechanisms may function to ensure the elimination of damaged cell death and protect the well being of the whole organism.
Conclusion
In summary, evolution may have modified a primitive dedicated programmed cell death mechanism, such as the one found in C. elegans, into multiple more flexible and adaptive cell death pathways. Several direct consequences may have resulted from this invention. First, the mammalian cell death mechanisms become highly responsive to a much broader variety of both internal and external stimuli. Rapid intracellular and extracellular information transfer is clearly critical for the survival of complex organisms such as mammals. Second, significant portions of cell death regulatory mechanisms may have been integrated into the signaling processes utilized under normal physiological and pathological conditions. A direct consequence of this integration is that caspases and Bcl-2 family are now involved in regulating cellular processes that may or may not be directly related to cell death. Many, if not all, of the proteins in the families of caspase and Bcl-2 are no longer dedicated regulators of cell death and may have secondary or even primary roles in regulating nonapoptotic processes. Finally, multiple normal physiological regulatory mechanisms may have been recruited to mediate cell death either as a backup or parallel mechanism of apoptosis. This is evident from the increasing numbers of such ''caspaseindependent'' cell death paradigms that have been documented in the literature. A direct consequence of such ''pluralism,'' however, is that inhibition of caspases becomes largely insufficient to prevent cell death and promote clonogenic survival in mammalian systems.
The extensive involvement of caspases in host defense response is particularly interesting. Because the programmed cell death mechanism mediated by ced-3 and ced-4 plays a role in defending C. elegans against Salmonella, an alternative possibility that one may consider is that the programmed cell death mechanism was originally evolved from a host defense mechanism.
The evolution of cell death mechanisms provides a beautiful example illustrating how gene duplications and genetic variations might allow the development of a primitive dedicated programmed cell death mechanism, similar to that of C. elegans, into a highly adaptive cell death mechanism in mammals. Although apoptosis and caspases play an important role in mammalian development, the roles of caspases have been significantly expanded during evolution from regulating cell autonomously controlled programmed cell death to multiple physiological processes. At the same time, the exclusive power of caspases, such as Ced-3, in regulating programmed cell death in primitive organisms has been significantly diluted in mammals. Multiple mechanisms have been recruited as alternative cell death mechanisms. Duplication of a primitive dedicated mechanism and interdigitizing it with other cellular processes may represent a general strategy of evolution that leads to the development of complex organisms.
